gild-20250331
0000882095
12/31
2025
Q1
false
365
729
455
iso4217:USD
xbrli:shares
xbrli:shares
iso4217:USD
iso4217:EUR
xbrli:pure
gild:designee
gild:patent
gild:claim
gild:lawsuit
gild:plaintiff
gild:segment
0000882095
2025-01-01
2025-03-31
0000882095
2024-12-31
0000882095
2025-03-31
0000882095
2025-04-30
0000882095
us-gaap:ProductMember
2025-01-01
2025-03-31
0000882095
us-gaap:ProductMember
2024-01-01
2024-03-31
0000882095
gild:RoyaltyContractAndOtherMember
2025-01-01
2025-03-31
0000882095
gild:RoyaltyContractAndOtherMember
2024-01-01
2024-03-31
0000882095
2024-01-01
2024-03-31
0000882095
us-gaap:CommonStockMember
2024-12-31
0000882095
us-gaap:AdditionalPaidInCapitalMember
2024-12-31
0000882095
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-12-31
0000882095
us-gaap:RetainedEarningsMember
2024-12-31
0000882095
us-gaap:NoncontrollingInterestMember
2024-12-31
0000882095
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-01-01
2025-03-31
0000882095
us-gaap:CommonStockMember
2025-01-01
2025-03-31
0000882095
us-gaap:AdditionalPaidInCapitalMember
2025-01-01
2025-03-31
0000882095
us-gaap:RetainedEarningsMember
2025-01-01
2025-03-31
0000882095
us-gaap:CommonStockMember
2025-03-31
0000882095
us-gaap:AdditionalPaidInCapitalMember
2025-03-31
0000882095
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-03-31
0000882095
us-gaap:RetainedEarningsMember
2025-03-31
0000882095
us-gaap:NoncontrollingInterestMember
2025-03-31
0000882095
us-gaap:CommonStockMember
2023-12-31
0000882095
us-gaap:AdditionalPaidInCapitalMember
2023-12-31
0000882095
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-12-31
0000882095
us-gaap:RetainedEarningsMember
2023-12-31
0000882095
us-gaap:NoncontrollingInterestMember
2023-12-31
0000882095
2023-12-31
0000882095
us-gaap:RetainedEarningsMember
2024-01-01
2024-03-31
0000882095
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-01-01
2024-03-31
0000882095
us-gaap:CommonStockMember
2024-01-01
2024-03-31
0000882095
us-gaap:AdditionalPaidInCapitalMember
2024-01-01
2024-03-31
0000882095
us-gaap:CommonStockMember
2024-03-31
0000882095
us-gaap:AdditionalPaidInCapitalMember
2024-03-31
0000882095
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-03-31
0000882095
us-gaap:RetainedEarningsMember
2024-03-31
0000882095
us-gaap:NoncontrollingInterestMember
2024-03-31
0000882095
2024-03-31
0000882095
country:US
gild:HIVProductsBiktarvyMember
2025-01-01
2025-03-31
0000882095
srt:EuropeMember
gild:HIVProductsBiktarvyMember
2025-01-01
2025-03-31
0000882095
gild:RestOfWorldMember
gild:HIVProductsBiktarvyMember
2025-01-01
2025-03-31
0000882095
gild:HIVProductsBiktarvyMember
2025-01-01
2025-03-31
0000882095
country:US
gild:HIVProductsBiktarvyMember
2024-01-01
2024-03-31
0000882095
srt:EuropeMember
gild:HIVProductsBiktarvyMember
2024-01-01
2024-03-31
0000882095
gild:RestOfWorldMember
gild:HIVProductsBiktarvyMember
2024-01-01
2024-03-31
0000882095
gild:HIVProductsBiktarvyMember
2024-01-01
2024-03-31
0000882095
country:US